PCV44 - EFFECTIVENESS OF SACUBITRIL/VALSARTAN VERSUS ENALAPRIL IN REDUCING MORTALITY AND HOSPITALIZATIONS COSTS FROM A MOROCCAN HOSPITAL PERSPECTIVE
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.591
https://www.valueinhealthjournal.com/article/S1098-3015(18)33891-9/fulltext
Section Title :
Section Order :
15
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33891-9&doi=10.1016/j.jval.2018.09.591